229 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (229)
- Addiction (4)
- Allergy, Asthma, & Immunology (1)
- Autoimmune Disorders (3)
- Bone & Muscle (2)
- Cancer (12)
- COVID-19 (Coronavirus) (8)
- Diabetes (6)
- Ear, Nose and Throat (6)
- Endocrine & Metabolic Disease (2)
- Gastrointestinal and Digestive Diseases (3)
- Hair and Skin Disorders (2)
- Healthy Volunteers (43)
- Heart Disease (20)
- Infectious Disease (11)
- Liver Disease (12)
- Lung Disease (2)
- Neurological Disorders (32)
- Nutrition (1)
- Obesity (9)
- Obstetrics & Gynecology (11)
- Pediatrics (17)
- Psychiatric Disorders (7)
- Rehabilitation (1)
- Stroke (2)
- Transplant (11)
- Vascular Conditions (1)
Displaying 1 - 2 of 2
Condition: Cancer / Bladder Cancer
Investigator: Alexander Wei, MD
Status: Currently Recruiting
The purpose of this study is to determine whether using LY4052031 in a type of cancer that may have tumor cells that express a protein called Nectin-4 is safe and how well the cancer responds to the study drug. LY4052031 has not been approved by the US Food and Drug Administration (FDA). This is a first in human study and all of the risks are not fully…
Condition: Heart Disease / Heart Failure
Investigator: Gabriel Sayer, MD
Status: Currently Recruiting
This is a prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Repair System in patients with heart failure and reduced ejection fraction (HFrEF).
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE